Drogsan Pharmaceuticals lead the way once more. For the first time in Turkey, a patented formulation domestic drug, developed at a medical faculty, was put into use by a domestic pharmaceutical company. "Storice", which includes Strontium + Licorice and developed by the Faculty Members of Sivas Cumhuriyet University, Faculty of Medicine, Department of Dermatology, was commercialized by Drogsan Pharmaceuticals and provided for the use of the health industry. With the ceremony hosted by the Rectorate of the University on October 31, 2018, a "Patented Formulation Commercialization Agreement" was signed between Drogsan Pharmaceuticals and Cumhuriyet University. Rector Prof. Alim Yıldız presented plaques of appreciation to the Turkish Medicine and Medical Devices Agency Vice President Recep Uslu, Medical Devices and Cosmetic Products Agency President Yücel Dener, Drogsan Pharmaceuticals CEO Mustafa Karpuzcu, Drogsan Pharmaceuticals General Manager Dr. Ersan Küçük, Sivas Cumhuriyet University Department of Dermatology Faculty Member Prof. Melih Akyol and Technocity Manager Dr. Serdar Mercan.
